CORE Biomedicine
CORE Biomedicine is a private, preclinical-stage biotechnology company that specializes in drug discovery and development for oncology.
CORE Biomedicine is a private, preclinical-stage biotechnology company that specializes in drug discovery and development for oncology.
CORE Biomedicine has raised $21.0M across 1 round. Its most recent round was a Series A of $21.0M in Jul 2026. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles, verified email addresses and LinkedIn profiles.
CORE Biomedicine is featured in
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.